PTPN6 and neoplasm: However, another study showed that Ptpn6 knockdown did not promote anti‐tumor immunity against B16 melanoma by transgenic T cells, unless checkpoint blockade was administered (Snook et al, 2020), raising questions on the conditions in which PTPN6 is relevant for antitumor T cell immunity.